$MDWK
MDWerks, Inc.

2023 Q2 Form 10-Q Financial Statement

#000149315223020562 Filed on June 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $64.08K $41.45K $78.42K
YoY Change 1934.29% 655.01% 3599.06%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $280.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $64.08K $41.45K $78.42K
YoY Change 1932.87% 655.03% 3599.06%
Operating Profit -$64.08K -$41.45K
YoY Change 1932.87% 654.48%
Interest Expense $5.676K $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net -$5.676K
YoY Change
Pretax Income -$69.75K -$41.45K -$78.42K
YoY Change 2114.29% 655.01% 776.2%
Income Tax
% Of Pretax Income
Net Earnings -$69.75K -$41.45K -$78.42K
YoY Change 2112.94% 655.03% 776.2%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 124.7M shares 123.3M shares 18.01M shares
Diluted Shares Outstanding 123.9M shares 122.7M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.940K $41.23K $23.72K
YoY Change
Cash & Equivalents $4.938K $41.23K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $4.938K $41.23K $23.72K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $88.00K
YoY Change
Goodwill
YoY Change
Intangibles $19.23K $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $107.2K -$2.00 -$23.72K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $4.938K $41.23K $23.72K
Total Long-Term Assets $107.2K -$2.00 -$23.72K
Total Assets $112.2K $41.23K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.524K $17.18K $34.48K
YoY Change -16.87% 2927.04%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $145.4K $0.00 $0.00
YoY Change -30.78% -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $149.9K $112.1K $128.1K
YoY Change -37.4% -52.58% -44.51%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $149.9K $112.1K $128.1K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $149.9K $112.0K $128.1K
YoY Change -37.4% -52.58% -44.51%
SHAREHOLDERS EQUITY
Retained Earnings -$558.9K -$489.2K -$430.7K
YoY Change 84.68% 46.5%
Common Stock $124.7K $123.4K $122.3K
YoY Change 592.59% 578.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$37.73K -$70.82K -$128.1K
YoY Change
Total Liabilities & Shareholders Equity $112.2K $41.23K
YoY Change

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$69.75K -$41.45K -$78.42K
YoY Change 2112.94% 655.03% 776.2%
Depreciation, Depletion And Amortization $280.00 $0.00
YoY Change
Cash From Operating Activities -$79.29K -$58.75K -$54.55K
YoY Change 802.05% 5775.4% 5095.24%
INVESTING ACTIVITIES
Capital Expenditures $88.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$107.5K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 150.5K $76.27K 54.55K
YoY Change 1612.17% 7526.7% 5095.24%
NET CHANGE
Cash From Operating Activities -79.29K -$58.75K -54.55K
Cash From Investing Activities -107.5K
Cash From Financing Activities 150.5K $76.27K 54.55K
Net Change In Cash -36.29K $17.51K 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$79.29K -$58.75K -$54.55K
Capital Expenditures $88.00K
Free Cash Flow -$167.3K -$58.75K
YoY Change 5775.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001295514
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 us-gaap Interest Expense
InterestExpense
usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q1 MDWK Noncash Investing Forgivenessof Debt
NoncashInvestingForgivenessofDebt
usd
CY2022Q1 MDWK Noncash Investing Forgivenessof Debt
NoncashInvestingForgivenessofDebt
usd
CY2023Q1 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
usd
CY2022Q1 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
usd
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
MDwerks, Inc.
CY2023Q1 dei Entity File Number
EntityFileNumber
000-56299
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-1095411
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
411 Walnut Street
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 20125
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Green Cove
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32043
CY2023Q1 dei City Area Code
CityAreaCode
(252)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
501-0019
CY2023Q1 dei Security12b Title
Security12bTitle
N/A
CY2023Q1 dei Trading Symbol
TradingSymbol
N/A
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
true
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
124734838 shares
CY2023Q1 us-gaap Cash
Cash
41228 usd
CY2022Q4 us-gaap Cash
Cash
23715 usd
CY2023Q1 us-gaap Assets
Assets
41228 usd
CY2022Q4 us-gaap Assets
Assets
23715 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
17175 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
34478 usd
CY2023Q1 MDWK Advances Payable Current
AdvancesPayableCurrent
94873 usd
CY2022Q4 MDWK Advances Payable Current
AdvancesPayableCurrent
104204 usd
CY2023Q1 us-gaap Liabilities
Liabilities
112048 usd
CY2022Q4 us-gaap Liabilities
Liabilities
138682 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
8957500 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
8957500 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
8957500 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
8957500 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
8958 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
8958 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
122260208 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
122260208 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
123401506 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
123401506 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
123401 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
122260 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
285988 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
201531 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-489167 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-447716 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-70820 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-114967 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
41228 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23715 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41451 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5494 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
41451 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
5494 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-41451 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5494 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-41451 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5494 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
122712732 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18010208 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
122712732 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18010208 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-230798 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-153713 usd
CY2022 MDWK Adjustments To Additional Paid In Capital Contributed Capital
AdjustmentsToAdditionalPaidInCapitalContributedCapital
30100 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
239444 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-114967 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-114967 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-114967 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
85598 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-41451 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-41451 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-70820 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-70820 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-41451 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5494 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-17303 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4494 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-58754 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1000 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
9331 usd
CY2023Q1 MDWK Proceeds From Subscription Agreements
ProceedsFromSubscriptionAgreements
85598 usd
CY2022Q1 MDWK Proceeds From Subscription Agreements
ProceedsFromSubscriptionAgreements
1000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
76267 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
17513 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23715 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
41228 usd
CY2023Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q1 us-gaap Common Stock Conversion Features
CommonStockConversionFeatures
Each share of Series A Convertible Preferred Stock is convertible into 100 shares of common stock, and each share of Series A Preferred Stock has the same number of common share votes prior to conversion as it would if fully converted to be used in voting on any company matter requiring a vote of shareholders.
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
8957500 shares
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_zVI8bznJkf0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zbzZVzRe3o0j">Use of Estimates and Assumptions</span> </b>- The preparation of financial statements in accordance with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Actual results can, and in many cases will, differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-41451 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-489167 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
17175 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
34478 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
9331 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
123401506 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
123401506 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1141298 shares
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
85598 usd
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
8957500 shares

Files In Submission

Name View Source Status
0001493152-23-020562-index-headers.html Edgar Link pending
0001493152-23-020562-index.html Edgar Link pending
0001493152-23-020562.txt Edgar Link pending
0001493152-23-020562-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
mdwk-20230331.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mdwk-20230331_def.xml Edgar Link unprocessable
mdwk-20230331_cal.xml Edgar Link unprocessable
mdwk-20230331_lab.xml Edgar Link unprocessable
mdwk-20230331_pre.xml Edgar Link unprocessable